Clinical Trial

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD

Name: A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD — clinical trial record (NCT07583849)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of a 12-week administration of HSK39004 inhalation powder in clinical trial participants with COPD

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-11

Trial Details

NCT Number	NCT07583849
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	376 participants
Start Date	2026-05-24
Primary Completion	2027-09-30 (estimated)
Study Completion	2027-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-10